181 related articles for article (PubMed ID: 35830566)
1. A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients.
Wang Z; Liu Y; Zhan X; Wang X; Zhang C; Qin L; Liu L; Qin S
Aging (Albany NY); 2022 Jul; 14(13):5571-5589. PubMed ID: 35830566
[TBL] [Abstract][Full Text] [Related]
2. Identification and verification of microtubule associated genes in lung adenocarcinoma.
Wei Y; Yang C; Wei J; Li W; Qin Y; Liu G
Sci Rep; 2023 Sep; 13(1):16134. PubMed ID: 37752167
[TBL] [Abstract][Full Text] [Related]
3. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
He J; Zhang W; Li F; Yu Y
Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a Lymph Node Metastasis-Associated Prognostic Signature for Lung Adenocarcinoma.
Yu J; Li G; Tian Y; Huo S
Genet Res (Camb); 2023; 2023():6585109. PubMed ID: 36793937
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
8. A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma.
Li X; Xu C; Min Y; Zhai Z; Zhu Y
Clin Respir J; 2023 Dec; 17(12):1349-1360. PubMed ID: 38071755
[TBL] [Abstract][Full Text] [Related]
9. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
Yang X; Wang G; Gu R; Xu X; Zhu G
PeerJ; 2020; 8():e10418. PubMed ID: 33304656
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma.
Chen J; Liu X; Wu Q; Jiang X; Zeng Z; Li J; Gao Y; Gong Y; Xie C
Cell Transplant; 2021; 30():9636897211055046. PubMed ID: 34705571
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma.
Yang C; Zhang J; Xie J; Li L; Zhao X; Liu J; Wang X
Curr Stem Cell Res Ther; 2024; 19(5):767-780. PubMed ID: 37455453
[TBL] [Abstract][Full Text] [Related]
13. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of an immune-associated signature in lung adenocarcinoma.
Wang Z; Chen X
Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
16. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
[TBL] [Abstract][Full Text] [Related]
17. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
[TBL] [Abstract][Full Text] [Related]
18. Osimertinib resistance prognostic gene signature: STRIP2 is associated with immune infiltration and tumor progression in lung adenocarcinoma.
Zhang G; Guan H; Ning YL; Yao K; Tang H; Muhetaer G; Li H; Zhou J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15573-15588. PubMed ID: 37648810
[TBL] [Abstract][Full Text] [Related]
19. Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes.
Zheng Z; Deng W; Yang J
Biomed Res Int; 2020; 2020():8832739. PubMed ID: 33490259
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma.
Li Z; Qi F; Li F
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
